Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 60.07 USD -6.23% Market Closed
Market Cap: 3.7B USD
Have any thoughts about
Rhythm Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc

Wall Street analysts forecast RYTM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RYTM is 61.85 USD with a low forecast of 52.52 USD and a high forecast of 80.85 USD.

Lowest
Price Target
52.52 USD
13% Downside
Average
Price Target
61.85 USD
3% Upside
Highest
Price Target
80.85 USD
35% Upside

RYTM Last Price Targets
Rhythm Pharmaceuticals Inc

The latest public price target was made on Nov 6, 2024 by Corinne Jenkins from Goldman Sachs , who expects RYTM stock to drop by 2% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Corinne Jenkins
Goldman Sachs
59 USD
Downside 2%
1 week ago
Nov 6, 2024
Rhythm Pharmaceuticals (RYTM) PT Raised to $59 at Goldman Sachs
StreetInsider
Alan Carr
Needham
64 USD
Upside 7%
1 week ago
Nov 6, 2024
Rhythm Pharmaceuticals (RYTM) PT Raised to $64 at Needham
StreetInsider
Raghuram Selvaraju
H.C. Wainwright
64 USD
Upside 7%
1 month ago
Sep 18, 2024
Rhythm Pharmaceuticals initiated with a Buy at H.C. Wainwright
TheFly
Jonathan Wolleben
JMP Securities
64 USD
Upside 7%
1 month ago
Sep 17, 2024
JMP Securities Starts Rhythm Pharmaceuticals (RYTM) at Market Outperform
StreetInsider
Alan Carr
Needham
55 USD
Downside 8%
3 months ago
Jul 25, 2024
Rhythm Pharmaceuticals (RYTM) PT Raised to $55 at Needham
StreetInsider
Corinne Jenkins
Goldman Sachs
Price Target 59 USD
Upside/Downside 2%
View Source
Alan Carr
Needham
Price Target 64 USD
Upside/Downside 7%
View Source
Raghuram Selvaraju
H.C. Wainwright
Price Target 64 USD
Upside/Downside 7%
View Source
Jonathan Wolleben
JMP Securities
Price Target 64 USD
Upside/Downside 7%
View Source
Alan Carr
Needham
Price Target 55 USD
Upside/Downside 8%
View Source
Rhythm Pharmaceuticals Inc Competitors:
Price Targets
ALLO
Allogene Therapeutics Inc
260% Upside
FOLD
Amicus Therapeutics Inc
72% Upside
ARGX
argenx SE
7% Downside
SOBI
Swedish Orphan Biovitrum AB (publ)
9% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
54% Upside
TSVT
2Seventy Bio Inc
104% Upside
SGMO
Sangamo Therapeutics Inc
59% Upside
XNCR
Xencor Inc
49% Upside

Revenue
Forecast

Revenue Estimate
Rhythm Pharmaceuticals Inc

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 63%.

N/A
Past Growth
63%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RYTM's stock price target?
Price Target
61.85 USD

According to Wall Street analysts, the average 1-year price target for RYTM is 61.85 USD with a low forecast of 52.52 USD and a high forecast of 80.85 USD.

What is Rhythm Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
63%

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 63%.

Back to Top